VOLIOTIS DIMITRIS (SVP, Clinical Development) sold 82.8% of their position (30K shares) of ZENTALIS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $1.84M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+10K
Price / share
$18.00
Trade value
$180K
% of position
Common Stock
Shares
−3.41K
Price / share
$61.70
Trade value
$210.33K
% of position
Common Stock
Shares
−3.29K
Price / share
$62.34
Trade value
$205.33K
% of position
Common Stock
Shares
−2K
Price / share
$63.48
Trade value
$126.77K
% of position
Common Stock
Shares
−1.30K
Price / share
$64.66
Trade value
$84.06K
% of position
Common Stock
Shares
+10K
Price / share
$18.00
Trade value
$180K
% of position
Common Stock
Shares
−7.89K
Price / share
$60.55
Trade value
$477.68K
% of position
Common Stock
Shares
−1.56K
Price / share
$61.51
Trade value
$95.71K
% of position
Common Stock
Shares
−555.00
Price / share
$62.24
Trade value
$34.54K
% of position
Common Stock
Shares
+10K
Price / share
$18.00
Trade value
$180K
% of position
Common Stock
Shares
−8.34K
Price / share
$60.52
Trade value
$504.90K
% of position
Common Stock
Shares
−1.66K
Price / share
$61.21
Trade value
$101.42K
% of position
Net shares
+0.00
Net value
-$1.30M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/18/2022 | M · Option Exercise | +10K | $18.00 | $180K | 160.0% | 6.25K | 16.25K |
| Common Stock Direct | 1/18/2022 | S · Sale | −3.41K | $61.70 | $210.33K | 21.0% | 16.25K | 12.84K |
| Common Stock Direct | 1/18/2022 | S · Sale | −3.29K | $62.34 | $205.33K | 25.7% | 12.84K | 9.55K |
| Common Stock Direct | 1/18/2022 | S · Sale | −2K | $63.48 | $126.77K | 20.9% | 9.55K | 7.55K |
| Common Stock Direct | 1/18/2022 | S · Sale | −1.30K | $64.66 | $84.06K | 17.2% | 7.55K | 6.25K |
| Common Stock Direct | 1/19/2022 | M · Option Exercise | +10K | $18.00 | $180K | 160.0% | 6.25K | 16.25K |
| Common Stock Direct | 1/19/2022 | S · Sale | −7.89K | $60.55 | $477.68K | 48.5% | 16.25K | 8.36K |
| Common Stock Direct | 1/19/2022 | S · Sale | −1.56K | $61.51 | $95.71K | 18.6% | 8.36K | 6.80K |
| Common Stock Direct | 1/19/2022 | S · Sale | −555.00 | $62.24 | $34.54K | 8.2% | 6.80K | 6.25K |
| Common Stock Direct | 1/20/2022 | M · Option Exercise | +10K | $18.00 | $180K | 160.0% | 6.25K | 16.25K |
| Common Stock Direct | 1/20/2022 | S · Sale | −8.34K | $60.52 | $504.90K | 51.3% | 16.25K | 7.91K |
| Common Stock Direct | 1/20/2022 | S · Sale | −1.66K | $61.21 | $101.42K | 21.0% | 7.91K | 6.25K |
| Total | +0.00 | -$1.30M | ||||||
Stock Option
Common Stock
10K shares
Shares
−10K
Strike price
18.0
Held after
144.95K
Exercisable
—
Stock Option
Common Stock
10K shares
Shares
−10K
Strike price
18.0
Held after
134.95K
Exercisable
—
Stock Option
Common Stock
10K shares
Shares
−10K
Strike price
18.0
Held after
124.95K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Direct | Common Stock10K shares | 1/18/2022 | M · Option Exercise | −10K | 18.0 | — | 144.95K |
| Stock Option Direct | Common Stock10K shares | 1/19/2022 | M · Option Exercise | −10K | 18.0 | — | 134.95K |
| Stock Option Direct | Common Stock10K shares | 1/20/2022 | M · Option Exercise | −10K | 18.0 | — | 124.95K |